miRNA Sequencing And Assay Market Analysis Report By Product & Service, By Technology, By Workflow, By Application, By End-use, By Region And Segment Forecasts From 2021 To 2028

Synopsis

The global miRNA sequencing and assay market were prized by USD 224.8 million in 2020. It is estimated to witness a 13.0% CAGR from 2021 to 2028.

Drivers

The growth of technically higher sequence analysis stage is anticipated to present an enlargement opportunity to the market for miRNA sequencing & assay. Sequence analysis of miRNA makes it possible the detect earlier non-characterized miRNA (micro RNAs); plus, helps in the assessment of miRNA isoforms, learning illness relations in addition to tissue precise appearance prototype.

Moreover, miRNA are the important biomarkers of a variety of sicknesses and the ignorance of their instructions might initiate the growth of cancer and additional serious complaints.

As, it presents a superior signal-to-noise percentage and makes it possible for the well-organized sequencing, miRNA sequence examination, using modern sequencing, is frequently chosen above microarrays.

Miniature RNAs, like siRNA, miRNA, piRNA, and others are, moreover, in the middle of cellular procedures like RNA-mediated epigenetic regulation of gene expression, apoptosis, differentiation, and cell development.

Application Insight

The cancer division held the major, 36.0% revenue share and led the miRNA sequencing and assay market, in 2020. Dysregulated miRNA has been considered like a new-fangled category of cancer suppressor gene, otherwise, oncomiR is performing a significant function in cancer instigation along with growth. The functioning contribution of several global associations in cancer research is anticipated to certainly affect the development of this vertical, during the forecast period.

The polyglutamine diseases application sector is likely to record the highest CAGR, during the forecast period. Precise appearance prototype of miRNA in the brain parenchyma plus passing around fluids and have been recognized as possible biomarkers for the prediction and analysis of polyglutamine sickness.

Workflow Insight

The sequencing workflow sector held the biggest, 53.3% revenue share, and led the miRNA sequencing & assay market, in 2020. Small RNA sequencing is turning into a well-liked method, to deal with numerous biological matters related to the ruling of miRNA plus additional minor non-coding RNAs. Sequence analysis, furthermore, assists to recognize and investigate a total variety of miRNA as well as miniature RNA classes. The library preparation sector retained the subsequent biggest revenue share of the market, in 2020.

Technology Insight

The Sequencing by Synthesis (SBS) technology sector held the biggest, 31.8% revenue share, and led the market, in 2020. The huge share of the sector is credited to the current research, along with the review in miRNA sequencing and assay using synthesis.

Product & Services Insight

As a result of the extensive function of miRNA sequencing and assay in the healthcare sector, the product division held the biggest, 80.9% revenue share of the market, in 2020. Besides, crucial companies present a broad variety of technically superior products, within this sector.

The service division is expected to grow up by a profitable percentage in the market, right through the forecast period. Several important companies present their services in miRNA sequencing and assay.

End-Use Insight

The research and academic institutes division held the biggest, 54.9% revenue share and led the miRNA sequencing and assay market, in 2020. Several educational institutions are getting proposals, to speed up the research, associated with miRNA sequencing and assay.

The pharmaceutical & biotechnology industry sector is anticipated to observe a sizeable CAGR, during the forecast period. The companies like Regulus Therapeutics are in the process of the growth of miRNA-sourced treatments.

Increasing funds to improve methods and tools, to conquer hand challenges in the scientific transformation of miRNA sequencing and assay functions, are expected to increase the expansion of the sector.

Regional Insight

North America held the biggest, 46.1% revenue share, and led the global market for miRNA sequencing and assay, in 2020. This share can be credited to the regional attendance of a large number of eminent companies, like PerkinElmer, Inc., Illumina Inc., Thermo Fisher Scientific, and others. The growth in the expenditure on research and development activities by main companies, to build up new and sophisticated products in the U.S., is anticipated to impel the expansion of the local market. For example, Illumina, Inc. used up USD 682 million for the research and development activities, to build up innovative sequence analysis tools plus improve the presented expertise.

The existence of numerous associations as well as the institutes working within this area, which find programs to increase alertness regarding new-fangled superior miRNA sequencing products as well as technology, impel the expansion of the provincial market.

Moreover, miRNA sequencing and assay are considerably accepted by agriculture laboratories, healthcare networks, military, and clinics, which obtain backing via government financial support. Therefore, sympathetic government regulations and funds are adding to the enlargement of the local market.

Due to the existence of a variety of associations and institutions, which are taking inventiveness to train young scientists within this region, the market is estimated to observe the highest expansion speed, during the forecast period, in the Asia Pacific. For example, in Asia Pacific AP Bio Net is a bioinformatics network. It is planned to follow the growth of the bioinformatics infrastructure, to exchange information and figures, in addition to carrying out conferences, teaching courses, and workshops.

Companies

Several companies, operating in the market for miRNA sequencing and assay, pursue a natural enlargement approach to strengthen their existence in the market. Thermo Fisher Scientific, Inc. and Illumina, Inc. are the two most important companies in the market. Additionally, the wide-ranging variety of the services as well as the products selection, presented by Illumina, Inc., has caused a growth in the revenue of the company in favor of miRNA sequencing and assay. Besides, an extensive delivery network of the company has considerably improved its share in the market.

Some of the companies for the miRNA sequencing and assay market are:

    • System Biosciences, LLC
    • HTG Molecular Diagnostics, Inc.
    • Norgen Biotek Corp
    • Takara Bio Inc.
    • Abcam plc
    • QIAGEN
    • Thermo Fisher Scientific, Inc.
    • Meridian Bioscience, Inc.
    • Maravai Life Sciences
    • Lexogen GmbH
    • New England Biolabs
    • PerkinElmer, Inc.
    • Illumina, Inc.

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2028. For this study, Million Insights has segmented the global miRNA sequencing and assay market report based on product & service, technology, workflow, application, end-use, and region:

• Product & Service Outlook (Revenue, USD Million, 2017 - 2028)
    • Products
        • Library Preparation Kits
        • Sequencing Consumables
        • Instruments
    • Services

• Technology Outlook (Revenue, USD Million, 2017 - 2028)
    • Sequencing (Seq.) By Synthesis
    • Seq. By Oligonucleotide Ligation and Detection (SOLiD)
    • Nanopore Seq.
    • Sanger Seq.
    • Single-Molecule Real-time (SMRT) Seq.

• Workflow Outlook (Revenue, USD Million, 2017 - 2028)
    • Library Preparation
    • Sequencing
    • Data Analysis & Storage

• Application Outlook (Revenue, USD Million, 2017 - 2028)
    • Cancer
    • Polyglutamine Diseases
    • Autoimmune Disease
    • Schizophrenia
    • Others

• End-use Outlook (Revenue, USD Million, 2017 - 2028)
    • Pharmaceutical & Biotechnology Industry
    • Research and Academic Institutes
    • Contract Research Organizations

• Regional Outlook (Revenue, USD Million, 2017 - 2028)
    • North America
        • U.S.
        • Canada
    • Europe
        • Germany
        • France
        • U.K.
        • Italy
        • Spain
    • The Asia Pacific
        • China
        • Japan
        • India
        • Australia
        • South Korea
    • Latin America
        • Brazil
        • Mexico
    • Middle East Africa (MEA)
        • South Africa
        • Saudi Arabia